Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus

Kodiak Sciences (KOD) incurred a loss of $1.09 per share in the first quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 89 cents. The company had incurred a loss of 82 cents per share in the year-ago quarter.The company currently does not have any approved products in its portfolio. As a result, it is yet to generate revenues. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)KOD's Q1 Results in DetailResearch and development expenses were $43.6 million in the repo ...